WL276 CAR-T Cell Therapy(Immunochina Medical Science & Technology)

N/A

Report date: 2025/07/26 20:00:09

Base Information

Drug NameWL276 CAR-T Cell Therapy(Immunochina Medical Science & Technology)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionCD276 antigen modulatorsT lymphocyte replacements

TargetsCD276 antigen

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesImunopharm Technology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesImunopharm Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A